Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 3;23(2):1613-1620.
doi: 10.1007/s40200-024-01459-7. eCollection 2024 Dec.

Assessing the efficacy of topical formulations in diabetic neuropathy: a narrative review

Affiliations
Review

Assessing the efficacy of topical formulations in diabetic neuropathy: a narrative review

Ali Elbeddini et al. J Diabetes Metab Disord. .

Abstract

Background: We conducted a review of topical medications available for alleviation of diabetic neuropathic pain (DNP) and compared their efficacy with oral medications for pain relief. We also explored the feasibility of compounding topical medications.

Methods: Searches on PubMed, Medline Ovid, and Embase databases were conducted and findings were presented as a narrative review.

Results and discussion: 8% Capsaicin patches and 5% Lidocaine patches had the most evidence. The literature also showed evidence for topical clonidine, gabapentin, and amitriptyline.

Conclusion: Topical formulations are a potential substitute to oral medications in patients suffering from DNP. Potential options include 8% Capsaicin patch, 5% Lidocaine patch, Clonidine gel, Topical gabapentin, and an amitriptyline and ketamine combination. A promising area of research that requires further study is the effect of a combination of topicals in alleviated DNP.

Keywords: Compounding services; Localized neuropathic pain; Patient safety.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declared that they have no conflict of interest.

Similar articles

References

    1. American Diabetes Association. 9. Microvascular complications and foot care. Diabetes Care. 2015;38(Supplement_1):S58–66. 10.2337/dc15-S012. - PubMed
    1. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72. 10.1056/NEJMoa0802987. - PubMed
    1. Millar WJ, Young TK. Tracking diabetes: prevalence, incidence and risk factors. Health Rep. 2003;14(3):35–47. - PubMed
    1. World Health Organization. World health organization global report on diabetes. Geneva: World Health Organization; 2016.
    1. Statistics Canada. Health fact sheets: chronic conditions, 2016. 2016. http://www.statcan.gc.ca/pub/82-625-x/2017001/article/54858-eng.htm. Accessed 20 Jan 2024

LinkOut - more resources